Case Control Study
Copyright ©The Author(s) 2023.
World J Gastrointest Pharmacol Ther. Dec 12, 2023; 14(5): 39-49
Published online Dec 12, 2023. doi: 10.4292/wjgpt.v14.i5.39
Table 2 Overview of standard of care practices
Dietary modifications
n = 1001
Concomitant supplements
n = 1001
Concomitant medication
n = 1001
FODMAP50 (50%)Prebiotics60 (60%)Rifaximin35 (35%)
Gluten-free51 (51%)Probiotics76 (76%)Eluxadoline22 (22%)
Keto36 (36%)Peppermint oil45 (45%)Antispasmodics12 (12%)
Elimination50 (50%)Fiber86 (86%)SSRIs8 (8%)
High fiber53 (53%)Ginger52 (52%)Tricyclic antidepressant8 (8%)
Low fiber43 (43%)Magnesium55 (55%)Anticholinergic medication14 (14%)
--Vitamin D57 (57%)Antidiarrheal medications32 (32%)
----Bile acid sequestrants9 (9%)
----Ondansetron8 (8%)